- Trials with a EudraCT protocol (2,838)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
2,838 result(s) found for: Cancer Surgery.
Displaying page 1 of 142.
EudraCT Number: 2012-004878-26 | Sponsor Protocol Number: 26842468452 | Start Date*: 2013-02-07 |
Sponsor Name:Karolinska University Hospital Solna | ||
Full Title: Antibiotic prophylaxis in patients undergoing primary or secondary breast reconstruction with implants, a randomized parallel two armed prospective clinical trial. | ||
Medical condition: The incidence of postoperative infections in patients with breast cancer or a history of breast cancer, after elective surgery with primary or secondary first-time breast reconstruction with implan... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: SE (Prohibited by CA) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002222-70 | Sponsor Protocol Number: Lidobreast | Start Date*: 2013-11-15 |
Sponsor Name:University Medical Centre St Radboud | ||
Full Title: Pilot study: Targeting the inflammatory response after breast cancer surgery with lidocaïne and dexamethasone | ||
Medical condition: Breast cancer patients who undergo surgery for treatment. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-003115-34 | Sponsor Protocol Number: V1 | Start Date*: 2012-06-06 |
Sponsor Name:Medizinische Universität Wien | ||
Full Title: A Collagen-Fibrin Patch (Tachosil®) for the Prevention of Symptomatic Lymphoceles after Pelvic Lymphadenectomy in Women with Gynecologic Malignancies: a Randomized Clinical Trial | ||
Medical condition: endometrial cancer, cervical cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-000135-40 | Sponsor Protocol Number: 260585 | Start Date*: 2016-05-12 | ||||||||||||||||||||||||||
Sponsor Name:Zealand University Hospital, Department of Surgery | ||||||||||||||||||||||||||||
Full Title: Endoscopic assisted electrochemotherapy in addition to neoadjuvant treatment of locally advanced rectal cancer: a randomized clinical phase II trial. | ||||||||||||||||||||||||||||
Medical condition: Locally advanced rectal cancer | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005090-20 | Sponsor Protocol Number: FADOI.01.2016 | Start Date*: 2018-05-17 | ||||||||||||||||
Sponsor Name:FONDAZIONE FADOI | ||||||||||||||||||
Full Title: Rivaroxaban or placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer: a randomized, double blind, placebo-controlled study. THE PRO-LAPS STUDY II | ||||||||||||||||||
Medical condition: Prevention of venous thromboembolism after laparoscopic surgery for colorectal cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001478-27 | Sponsor Protocol Number: IRFMN-GCC-7813 | Start Date*: 2019-09-11 | |||||||||||
Sponsor Name:Associazione Chirurghi Ospedalieri Italiani | |||||||||||||
Full Title: Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery in gastric carcinoma at high risk of peritoneal carcinomatosis. Short and long-term outcomes.... | |||||||||||||
Medical condition: Patients with gastric carcinoma at high risk of developing peritoneal carcinomatosis, suitable to radical surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001566-21 | Sponsor Protocol Number: 4767 | Start Date*: 2018-01-29 | |||||||||||
Sponsor Name:Ismail Gögenur [...] | |||||||||||||
Full Title: Effect of Low-dose Interferon-alfa2a on post-operative immune suppression - a randomized trial | |||||||||||||
Medical condition: Colon cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004567-11 | Sponsor Protocol Number: 75911 | Start Date*: 2020-12-08 | |||||||||||
Sponsor Name:Zealand University Hospital | |||||||||||||
Full Title: Effect of Low-dose Interferon-alfa2a on peri operative immune suppression | |||||||||||||
Medical condition: pMMR Colon cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002997-29 | Sponsor Protocol Number: D9106C00001 | Start Date*: 2019-01-07 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Phase III, Double-blind, Placebo-controlled, Multi-center International Study of Neoadjuvant/adjuvant Durvalumab for the Treatment of Patients with Resectable Stages II and III Non-small Cell Lun... | |||||||||||||
Medical condition: Patients with resectable Non-small Cell Lung Cancer (Stage IIA to IIIB; either squamous or non-squamous) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Ongoing) AT (Ongoing) BG (Completed) ES (Ongoing) NL (Ongoing) PL (Ongoing) DE (Ongoing) FR (Ongoing) BE (Ongoing) IT (Ongoing) RO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-006831-10 | Sponsor Protocol Number: 1199.15 | Start Date*: Information not available in EudraCT | ||||||||||||||||||||||||||
Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG | ||||||||||||||||||||||||||||
Full Title: Multicenter, randomised, double-blind Phase III trial to investigate the efficacy and safety of BIBF 1120 in combination with carboplatin and paclitaxel compared to placebo plus carboplatin and pac... | ||||||||||||||||||||||||||||
Medical condition: Advanced ovarian cancer, fallopian tube cancer or primary peritoneal cancer | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||||||||||||
Trial protocol: DE (Completed) FR (Completed) SE (Completed) BE (Completed) PT (Completed) SK (Completed) DK (Completed) AT (Completed) NL (Completed) FI (Completed) PL (Completed) IT (Completed) GR (Completed) CZ (Completed) ES (Completed) GB (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-004213-41 | Sponsor Protocol Number: RIPAC | Start Date*: 2019-06-12 | |||||||||||
Sponsor Name:University Hospital Ghent | |||||||||||||
Full Title: Effect of intravenous replenishment of iron in the preoperative management of anemia in patients with colon cancer: RIPAC-trial | |||||||||||||
Medical condition: M0-stage colon carcinoma with iron deficiency anemia defined by a Hb lower than 13 g/dl in men and 12g/dl in women with a transferrin saturation lower than 20% | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003074-27 | Sponsor Protocol Number: SMS-0472B | Start Date*: 2018-11-30 |
Sponsor Name:WntResearch | ||
Full Title: A Randomized, Multicentre, Open-Label Controlled Phase II Trial of Foxy-5 as Neo-Adjuvant Therapy in Subjects with Wnt-5a Low Colon Cancer. | ||
Medical condition: Subjects with resectable adenocarcinoma of the colon and who, at the time of screening, are considered to fulfil the local criteria for adjuvant post-operative chemotherapy. Based on CT/MRI subject... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Temporarily Halted) NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-017137-22 | Sponsor Protocol Number: 190178 | Start Date*: 2013-04-16 |
Sponsor Name:Klinische Abteilung für Thorax -u. Hyperbare Chirurgie, Medizinische Universität Graz | ||
Full Title: Clinical course after substitution of Vitamin-D deficiency in patients with lung cancer or oesophageal carcinoma. Double blind randomised prospective, placebo-controlled study. | ||
Medical condition: Patients admitted for treatment on a general thoracic surgery division with the following conditions: Lung cancer Esophageal cancer Cancer of the gastroesophageal junction (GEJ) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-003530-13 | Sponsor Protocol Number: 18072011 | Start Date*: 2011-12-20 | |||||||||||
Sponsor Name:Brighton & Sussex University Hospitals NHS Trust | |||||||||||||
Full Title: Randomised phase II window study of short-term preoperative treatment with the PI3K inhibitor GDC-0941 plus Anastrozole versus Anastrozole alone in patients with ER-positive primary breast cancer | |||||||||||||
Medical condition: Primary breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002409-23 | Sponsor Protocol Number: 2012/421 | Start Date*: 2012-09-21 | |||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||
Full Title: Coagulation Profile in Patients Undergoing Video Assisted Thoracoscopic Surgery (VATS) for lung cancer - a randomized, controlled trial | |||||||||||||
Medical condition: Coagulation profile in patients undergoing lung surgery due to cancer in the lung. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007798-18 | Sponsor Protocol Number: AIO/CAO-STO-0801 | Start Date*: 2010-07-01 | ||||||||||||||||
Sponsor Name:AIO-Studien-gGmbH | ||||||||||||||||||
Full Title: An Open Label Randomized Controlled Phase II Trial of Panitumumab in Combination with Epirubicin, Cisplatin and Capecitabine (ECX) versus ECX Chemotherapy alone in Subjects with Locally Advanced Ga... | ||||||||||||||||||
Medical condition: Subjects with Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000404-11 | Sponsor Protocol Number: M20TES | Start Date*: 2021-02-02 |
Sponsor Name:Princess Margaret Cancer Centre | ||
Full Title: FIGO 2018 stage IB2 (>2cm - ≤4 cm) Cervical Cancer Treated with Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery (CoNteSSa) / Neo-Adjuvant Chemotherapy and Conservative Surgery in Cer... | ||
Medical condition: Women between 18 en 40 years with histologically confirmed invasive cervical cancer with adenocarcinoma, adenosquamous or squamous histology and FIGO 2018 IB2 measuring >2cm to ≤4cm | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005240-93 | Sponsor Protocol Number: 1.3_amendment patientantal | Start Date*: 2007-03-13 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: The effect of localanastetic when the drainage is removed, including women operated for breast cancer. [Svensk titel: effekt av lokalbedövning vid dränage borttagning]. | ||
Medical condition: Patients undergoin surgery for breast cancer, according to DSMIV. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001191-30 | Sponsor Protocol Number: IISR-2015-101127 | Start Date*: 2017-04-25 | |||||||||||
Sponsor Name:Department of Obstetrics & Gynecology, Copenhagen University Hospital, Rigshospitalet | |||||||||||||
Full Title: Use of TachoSil® for the prevention of postoperative complications after groin dissection in vulva cancer patients | |||||||||||||
Medical condition: Vulva cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000760-18 | Sponsor Protocol Number: 13.034 | Start Date*: 2014-11-24 |
Sponsor Name:Prof. Peter Licht | ||
Full Title: Supplementary Epidural Analgesia in Video-Assisted Thoracic Surgery (VATS) - The SEAVATS Study. | ||
Medical condition: Cancer pulmones | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.